Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 July 2020 | Story Andre Damons | Photo Supplied
Dr Champion N Nyoni.

As yet another testament to the great work being done, as well as the dedication, passion, and hard work of staff members in the School of Nursing at the University of the Free State (UFS), a senior lecturer became the first UFS staff member to win the prestigious Sigma Emerging Nurse Researcher/Scholar award – making him only the third African to win this award. 

“I was overwhelmed to be honoured with this award as the third African to have won it in the history of the awards. To me, this is an indication that the quality of our work in the School of Nursing is top-notch and meets international standards, and that our contribution to nursing science and nursing education is outstanding,” says a proud Dr Champion N. Nyoni on his latest achievement. 

Sigma Theta Tau International (Sigma) is a global honour society for nurses that recognises and advances nursing through research and scholarship. Membership for this society includes a minimum of a master’s qualification and nomination from current members based on your contribution and the potential thereof for nursing at a national and global scale. 

The Emerging Nurse Researcher/Scholar Award, with the purpose of recognising nurses whose research and scholarship has impacted the profession and the people it serves, was introduced in 2015.

No easy process 
It is quite a rigorous process to become eligible for the award, explains Dr Nyoni. “One is nominated by peers who are also part of Sigma; these peers must motivate their nomination by providing evidence related to the research and scholarship of the nominee.” 

“In addition to the numerous reference reports from colleagues in the discipline of nursing, additional referrals are sought from colleagues in other professions (in the health sciences) who have worked and engaged with the research of the nominee. This application process is then evaluated for consideration, among others, by a global panel. I never thought that I would win this award, given the nature of the nomination process, and the heavy funding that other nurse researchers globally receive in comparison to Africa,” says Dr Nyoni.

According to a passionate Dr Nyoni, the award will also give him the energy to continue an academic track, especially in nursing and nursing education, with a focus on improving the quality of nursing education, the quality of nursing graduates, impacting the nursing workforce and thereby influencing the quality of health indicators, especially in Africa, where health systems are nurse-driven. 

Dr Nyoni is appreciative of the nurturing environment and brilliant colleagues in the School of Nursing, who are supporting his research career.

Quality nursing education

"We need quality nurses for quality nursing care, and this should be done through quality nursing education. I hope to use this award as part of a motivation strategy for young nurses to be engaged in scholarship and in academia, as there is a great need, especially in sub-Saharan Africa,” concludes Dr Nyoni.

When he was nominated, Dr Nyoni had close to 15 publications in nursing education and close to 40 presentations at local and international conferences. He also had several awards for his research work, including the Best Education Paper: Senior Category at the Faculty of Health Science’s Research Forum in 2019. 

Dr Nyoni is currently a postdoctoral fellow (the first) in the UFS School of Nursing and serves as chairperson on several boards of directors relating to health professions education in the African region, namely AfrIPEN and SAFRI. He is also supervising several master’s and PhD students.
 
• This award will be presented on Thursday at the International Nursing Research Congress that is now taking place online due to COVID-19.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept